patient preference for treatment in ovarian cancer
Published 3 years ago • 62 plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
3:59
determining a woman's preference for treatment options in ovarian cancer - dr. laura havrilesky
-
26:02
updates in ovarian cancer: frontline maintenance
-
3:47
rationale for immunotherapy in ovarian cancer
-
7:44
frontline treatments in ovarian cancer
-
0:31
ovarian cancer patient has extraordinary response to clinical trial treatment
-
0:45
dr. sabbatini on novel approaches with ip therapy for ovarian cancer
-
4:34
endometrial cancer uterus fda approved treatment - dr robert debernardo, md
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
9:08
factors in choice of treatment for recurrent ovarian cancer
-
3:48
outlook in treating patients with ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
4:07
expert approaches for treating recurrent ovarian cancer
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
3:40
paola-1: combination maintenance therapy in ovarian cancer
-
1:06
dr. birrer on patient preferences for cervical cancer treatment
-
34:43
treatments for recurrent ovarian cancer
-
9:37
promising treatments in ovarian cancer